Stay updated on Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial
Sign up to get notified when there's something new on the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page.

Latest updates to the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the Phase 3 B-VEC study now displays its study details and results, along with participant eligibility, treatment design, and locations. It also includes study documents, record dates, and related resources.SummaryDifference49%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden response.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide NIH notice was added above the ClinicalTrials.gov navigation, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record page now shows a 403 Forbidden error instead of the trial details for the NCT04491604 study. This blocks access to the study information and replaces it with a standard error screen.SummaryDifference18%

Stay in the know with updates to Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page.